NAC also grants stock options to Directors and
Employees
OTTAWA, May 7, 2018 /CNW/ - National Access Cannabis
Corp. ("NAC" or the "Company") (TSXV: NAC),
Canada's best practices leader in
delivering secure, safe, and responsible access to legal cannabis
today announced that Felipe
Campusano has joined the Company's Board of Directors. The
Company also announces the resignation of Jeff Hunt from the Board of Directors.
"Although we are actively building a dominant recreational
retail foot print across Western
Canada, NAC has not lost sight of the importance of our
medical clinic practice to Canadians exploring the benefit of
prescription cannabis," said Mark
Goliger, Chief Executive Officer of National Access
Cannabis. "We're very fortunate to have Felipe join our Board,
bringing important insight and experience in successfully operating
Canadian pharmacies. With his valuable insight and guidance, we
will look to expand our initial network of 40 pharmacies to
hundreds more across Canada.
Developing a strong pharmacy program will provide NAC with strong
credibility and brand recognition and opportunities to license the
business system in international markets, like Germany."
Mr. Goliger added: "I, along with the board members and
management of the Company, thank Jeff for his guidance and
dedication to NAC and his ongoing commitment to remain a brand
ambassador after his departure."
Felipe Campusano graduated from
The University of Toronto Faculty of
Pharmacy in 2006. Concurrent with the day he received his license,
Campusano purchased his first pharmacy in a remote location of
Northern Ontario. Over the course
of the last 12 years Felipe had accumulated interest in over 50
pharmacies across Canada. He is
one of the founding Partners and current President of Liver Care
Canada a company that facilitates treatments of all liver
diseases.
The Company also announces that on May 7,
2018 the board of directors of the Company granted an
aggregate of 600,000 stock options (the "Options") to
purchase common shares of the Corporation ("Shares") to
certain directors, officers, employees and consultants of the
Corporation. The Options vest on a monthly basis for 12 months and
are exercisable for a period of five years from the date of grant
at an exercise price of $0.86 per
Share. Each grant of Options is subject to the approval of the TSX
Venture Exchange.
About National Access Cannabis
National Access Cannabis is Canada's best practices leader in delivering
secure, safe, and responsible access to legal cannabis. Through its
Canada-wide network of care
centres and retail locations, NAC enables patients and the public
to gain knowledge and access to Canada's disparate network of authorized
Licensed Producers of Cannabis. NAC improves the quality of life of
its local clients and provides services designed to inform, educate
and supply expert advice.
For more information, visit www.nationalaccesscannabis.com or
refer to the Company's profile on the SEDAR website at
www.sedar.com.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
SOURCE National Access Cannabis Corp.